Pamela Spence
Partner, Global Life Sciences Industry Leader


In this keynote, Pamela Spence, EY’s Global Life Sciences Industry Leader, outlines how platform business models that seamlessly and precisely combine products and services to deliver better health outcomes are central to creating and capturing value in today’s dynamic landscape. Spence will explain how the emergence of holistic platforms of care create opportunities to promote greater customer-centricity, improved access to care, and a far clearer picture of health and disease than ever before. To remain relevant in this new era of decision medicine, traditional life sciences companies must rebalance their commercial organizations and rethink the role Medical Affairs has traditionally played, shifting from product-centric messaging to predictive and personalized support, especially for older and sicker individuals.


[mepr-show if=”rule: 4078″]

Precision Health 4.0


[mepr-hide if=”rule: 4078″]

[mepr-show if=”loggedin”]

Your subscription has expired. To view this content, please visit your account page to purchase a new subscription.


[mepr-show if=”loggedout”]

Please login or purchase a membership to view this content.




Stay Connected with MAPS

Join MAPS on LinkedIn to further build your professional connections within Medical Affairs through our Company and Group Pages.

Follow us on Twitter and say abreast of MAPS activities and key issues for Medical Affairs professionals.